TENX

TENAX THERAPEUTICS, INC.

Healthcare · Biotechnology

$272.38 sample

-2.48 (-0.90%) 1D

Market cap

$626.1B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-28

Alerts

8

Price$272.38 -0.48% 3M daily closessample

283.65255.96

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28SECForm 144 filed
Sep 18INSInsider buy: EVP, Operations
Sep 14INSInsider buy: EVP, Operations
Sep 03SEC10-Q filed
Aug 25INSInsider sell: EVP, Operations
Aug 20INSInsider buy: Chief Executive Officer
Aug 12INSInsider sell: Chief Financial Officer
Aug 07SEC10-Q filed

Sign up to see the real TENX record →

Company facts

SEC EDGAR registration

Name: TENAX THERAPEUTICS, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -48sample, -100 to +100
Reporting currency: USD

Who is positioning in TENX

sample

Insiders: 33 insider transactions over 90 days, net selling, $24.9M
Congress: No member trades over 90 days
Institutions · 13F: 28 funds hold $9.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$23.3B +18.6% y/y

Q4 2024Q3 2026

Inventory$13.9B +15.5% y/y

Q4 2024Q3 2026

Accounts receivable$10.7B +9.2% y/y

Q4 2024Q3 2026

Total debt$28.4B +10.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $268.2B +16.4% 3M
Sample peer B: $304.4B +4.6% 3M
Sample peer C: $75.1B +10.0% 3M
Sample peer D: $78.8B -9.0% 3M
Sample peer E: $537.5B +9.7% 3M